Fluvoxamine Prevents Symptoms From Worsening In Patients With SARS-CoV-2 Who Were Not Hospitalized In Small Randomized Controlled Trial
November 13, 2020
STAT (11/12, Cooney, Herper) reports researchers at Washington University found in “a small randomized controlled trial” that fluvoxamine “prevented symptoms of” patients with SARS-CoV-2 who were not hospitalized “from worsening compared to placebo.” The...